GenBioPro Inc., which makes a generic version of the abortion-ending drug mifepristone, has dropped its challenge to a West Virginia law that precludes doctors in the state from prescribing its product.
Judge Robert C. Chambers, of the US District Court for the Southern District of West Virginia, on Monday granted the a joint stipulation to enter final judgment and end the case. The agreement was signed by the drugmaker, West Virginia Attorney General Patrick Morrisey (R), and Putnam County Prosecuting Attorney Kristina Raynes. Mifepristone is part of a two-drug regimen used to end pregnancies at their earliest stages.
The dismissal ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.